Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Diabetes management Stories

2013-09-09 08:27:53

-- Funding Will Support Broad Scale Commercialization of CeQur PaQ® Insulin Delivery Device- HORW, Switzerland, Sept. 9, 2013 /PRNewswire/ -- CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced the closing of a $27 million dollar Series B financing. The financing was led by two new private investors with the participation of all current shareholders, and will support manufacturing scale up for the CeQur PaQ(®) simple...

2013-09-08 23:01:00

mhealth Apps and Solutions Market By Connected Devices (Cardiac Monitoring, Diabetes Management Devices), Health Apps (Exercise, Weight Loss, Women’s Health, Sleep and Meditation), Medical Apps (Medical Reference) – Global Trends and Forecast to 2018 is the new research report available at RnRMarketResearch.com. Dallas, Texas (PRWEB) September 08, 2013 The global mHealth market is estimated to be valued at $6.6 billion in 2013 and is expected to reach $20.7 billion by 2018 at a...

2013-09-06 12:21:58

BOSTON, Sept. 6, 2013 /PRNewswire/ -- TechAtlas Group has announced the release of the latest Type 1 Diabetes (T1DM) competitive landscape map. This particular landscape highlights 71 international companies with over 140 drugs and devices currently on the market and in development. (Logo: http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) Topics include: -- Save the cells: immune therapies for T1DM -- Beta-cell regeneration strategies -- Pancreatic replacement via...

2013-09-04 08:18:58

A study based on a nationally representative sample of adults in China in 2010 indicates that nearly 12 percent of Chinese adults had diabetes and the prevalence of prediabetes was about 50 percent, according to a study in the September 4 issue of JAMA. "Noncommunicable chronic diseases have become the leading causes of mortality and disease burden worldwide. It was estimated that 34.5 million deaths globally were due to noncommunicable diseases in 2010, which reflected a significant...

Diabetes Treatment Without The Insulin - Leptin May Be The Key
2013-09-04 05:26:19

redOrbit Staff & Wire Reports - Your Universe Online Researchers at the University of Geneva (UNIGE) report they have discovered the underlying biological mechanisms responsible for insulin deficiencies in diabetic patients – research they believe could end the need for regular injections and result in new types of treatment for the condition. Insulin is a hormone secreted by beta cells in the pancreas, and deficiencies of it plays a major role in the regulation of glucose and...

2013-09-03 12:26:50

DETROIT, Sept. 3, 2013 /PRNewswire-USNewswire/ -- The Southeast Michigan Beacon Community (SEMBC) today announced that it has achieved six of seven target measures in the care of patients with type 2 diabetes that are part of its Clinical Transformation efforts. When it was activated in March of 2011, a primary goal of SEMBC was to use health information technology (HIT) and clinical transformation strategies to achieve specific targets in high impact quality measures related to the care of...

Medical Trials Offer Positive Results For Specific Class Of Diabetes Drug
2013-09-03 07:59:01

redOrbit Staff & Wire Reports - Your Universe Online While a new class of diabetes pill known as DPP-4 inhibitors does not appear to increase a person’s risk of heart attack, there is some indication that there could be other negative cardiovascular effects associated with the drugs. According to Reuters reporter Ben Hirschler, some of the medications – which are a class of oral hypoglycemics that block a protein that plays a major role in glucose metabolism – were linked to a...

2013-09-02 04:21:34

Clinical Data Published in the New England Journal of Medicine and Presented at the ESC Congress 2013 AMSTERDAM, The Netherlands and OSAKA, Japan, Sept. 2, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) today announced results of the EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) cardiovascular (CV) safety outcomes trial, showing the primary endpoint of...

2013-08-29 23:02:28

Glucose monitoring systems with an autocorrect feature that can detect red blood cells (hematocrit), vitamin C and other common interferents in burn patients’ blood are better for monitoring care, a pilot study conducted by UC Davis researchers at the School of Medicine and College of Engineering has found. Sacramento, CA (PRWEB) August 29, 2013 Glucose monitoring systems with an autocorrect feature that can detect red blood cells (hematocrit), vitamin C and other common interferents in...

2013-08-28 08:27:28

Primary investigator presents results at the World Federation of Societies of Intensive and Critical Care Medicine (WFSICCM) Congress OXFORD, England, August 28, 2013 /PRNewswire/ -- GlySure Limited, developer of in-hospital continuous blood glucose monitoring (CBGM) systems, today announced that a study demonstrating the effectiveness of its technology in continuously measuring blood glucose levels in post-surgical cardiac surgery patients will be presented at the World...


Latest Diabetes management Reference Libraries

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

More Articles (1 articles) »